Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266)
A2697
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameEnavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionEnavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) is a humanized monoclonal antibody directed against the tumor necrosis factor-like weak inducer of apoptosis receptor (TWEAKR) with potential antineoplastic, immunomodulating and antiangiogenic activities. MW : 150 kD.
- Storage Instruction-20°C
- UNSPSC12352203